Enjoy complimentary customisation on priority with our Enterprise License!
The inhalation anesthesia market size is forecast to increase by USD 318.2 million at a CAGR of 4.5% between 2024 and 2029.
The inhalation anesthesia industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.
The sevoflurane segment is estimated to witness significant growth during the forecast period.
The market encompasses various entities, including pediatric anesthesia, aerosol delivery, pharmacodynamic studies, anesthetic agents, clinical practice guidelines, endoscopic surgery, regional anesthesia, drug concentration monitoring, nitrous oxide, inhaled anesthetics, monitoring devices, reusable circuits, anesthesia services, ambulatory surgery, pharmacokinetic studies, clinical trials, geriatric anesthesia, anesthesia provider, anesthesia technician, anesthesia care, volatile anesthetics, obstetric anesthesia, anesthesia record keeping, drug interactions, anesthesia delivery systems, electronic medical records, disposable circuits, robotic surgery, anesthesia protocols, dental anesthesia, critical care, anesthesia machines, patient satisfaction, automated delivery, surgical procedures, adverse events, general anesthesia, patient safety, best practices, halogenated anesthetics, postoperative recovery, efficacy studies, drug delivery, outpatient surgery, breathing circuits, closed-loop systems, anesthesia guidelines, anesthesia circuits, anesthesia workstations, inhalational anesthetics, quality improvement, minimally invasive surgery, safety studies, precision delivery, pain management, and non-halogenated anesthetics.
Sevoflurane, an inhaled anesthetic agent, is gaining popularity due to its effectiveness in geriatric anesthesia. Its use is increasing in dental, surgical, and gynecological procedures due to its affordability and ease of handling compared to other gases. In 2023, the preference for minimally invasive procedures led to a surge in demand for sevoflurane, contributing significantly to the growth of the market. Endoscopic surgery, a minimally invasive procedure, is increasingly being adopted for various surgical interventions, further fueling the demand for inhalation anesthetics like sevoflurane. Moreover, the advancements in anesthesia delivery systems, such as closed-loop systems and automated delivery, enable precise drug delivery and improved patient safety.
These systems are increasingly being integrated into clinical practice, enhancing the quality of anesthesia care. Additionally, the growing emphasis on patient satisfaction and postoperative recovery has led to the development of anesthesia protocols and guidelines to optimize patient outcomes. In conclusion, the market is witnessing significant growth due to the increasing demand for minimally invasive procedures, the adoption of advanced anesthesia delivery systems, and the development of anesthesia protocols and guidelines to ensure optimal patient outcomes. Sevoflurane, an inhaled anesthetic agent, is gaining popularity due to its effectiveness in geriatric anesthesia and ease of handling, contributing significantly to the growth of the market.
The Sevoflurane segment was valued at USD 671.50 million in 2019 and showed a gradual increase during the forecast period.
North America is estimated to contribute 40% to the growth of the global market during the forecast period.Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The market in North America is experiencing significant growth due to several factors. The increasing prevalence of chronic diseases necessitates an elevated demand for surgical procedures, leading to increased usage of anesthesia. In 2023, approximately 120 million Americans were living with at least one major chronic disease, such as heart disease, cancer, diabetes, obesity, or hypertension. Furthermore, around 1.9 million new cancer cases and 600,000 cancer-related deaths were reported in the US that year. Advanced technologies, like aerosol delivery systems, automated anesthesia delivery, and closed-loop systems, are gaining popularity due to their precision and efficacy in administering anesthetics.
The adoption of these technologies is also driven by the rising incidence of endoscopic surgeries, robotic procedures, and minimally invasive surgeries. Additionally, the increasing geriatric population and the presence of prominent anesthesia providers, anesthesia technicians, and healthcare institutions are further fueling market growth. Inhalational anesthetics, such as volatile and non-volatile agents, are widely used for general, pediatric, obstetric, dental, and critical care anesthesia. Anesthesia services, including anesthesia care, drug monitoring, and record keeping, are crucial components of the market. Patient safety, best practices, and quality improvement initiatives are essential considerations for anesthesia providers. Drug interactions, adverse events, and postoperative recovery are critical factors influencing patient satisfaction and clinical outcomes.
Pharmacodynamic and pharmacokinetic studies, clinical trials, and safety studies are ongoing to enhance the efficacy and safety of anesthetic agents. Inhalation anesthetics are also used in emergency medicine and veterinary medicine. The market is expected to continue its growth trajectory due to these trends and the increasing demand for advanced anesthesia delivery systems and pain management solutions.
Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The inhalation anesthesia market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the inhalation anesthesia market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, inhalation anesthesia market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
AbbVie Inc. - Inhalation anesthesia, including Ultane, plays a crucial role in the medical field for inducing and maintaining general anesthesia during surgical procedures. This anesthetic method delivers anesthetic agents directly to the lungs, ensuring rapid onset and effective analgesia. Ultane, specifically, is a commonly used inhalation anesthetic, contributing significantly to the safety and efficiency of surgical interventions. Its application enhances patient comfort and reduces the risk of complications associated with traditional anesthesia administration methods.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The anesthesia market encompasses various aspects, including workflow, equipment, protocols, gas management, vaporized anesthesia, research, education, licensing, and compliance. Anesthesia workflow optimization is a significant trend, with advanced technology streamlining processes and improving patient outcomes. Anesthesia equipment, such as anesthesia machines and monitors, continue to evolve, offering enhanced functionality and safety features. Anesthetic gas management systems ensure efficient and safe delivery of anesthesia gases, while anesthesia billing and reimbursement remain crucial aspects of practice management. Compliance with regulations, accreditation, certification, and standards is essential for maintaining a reputable anesthesia practice.
Inhaled drug delivery systems, anesthesia technology, and risk management tools are driving innovation in the market. Anesthesia coding, supplies, consumables, monitoring, and safety are integral components of effective anesthesia practice and patient care.
Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Inhalation Anesthesia Market insights. See full methodology.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
191 |
|
Base year |
2024 |
|
Historic period |
2019-2023 |
|
Forecast period |
2025-2029 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 4.5% |
|
Market growth 2025-2029 |
USD 318.2 million |
|
Market structure |
Concentrated |
|
YoY growth 2024-2025(%) |
4.2 |
|
Key countries |
US, Canada, China, UK, Germany, Japan, India, Italy, South Korea, and France |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
We can help! Our analysts can customize this inhalation anesthesia market research report to meet your requirements.
1 Executive Summary
2 Technavio Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Product
9 Market Segmentation by Application
10 Market Segmentation by End-user
11 Market Segmentation by Route of Administration
12 Market Segmentation by Procedure Type
13 Market Segmentation by Distribution Channel
14 Customer Landscape
15 Geographic Landscape
16 Drivers, Challenges, and Opportunity/Restraints
17 Competitive Landscape
18 Competitive Analysis
19 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
